MEDIA
PDC Therapeutics building better docetaxel therapy with nanocarrier technology
RS Research has raised $12M in Series-A investment round with GEN Ilac as the lead investor
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
RS Research was listed 13th in Fast Company’s 50 Most Innovative Companies 2024
RS Research has been selected to join the the inaugural cohort of prestigious Turcorn100 Program
Turkey’s Promising biotech startup raises $12M in Series A Investment Round
Turkish company RS Research received the Entrepreneur of the Year Award
Big Business Through Cultural Cooperation Between Turkey and The US: “Move Turkey To Forward in Health
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER
Developing smart chemotherapy drugs against cancer, RS Research kicks-off Series-A funding round
Move Turkey Forward in Healthcare with 100-billion-dollar trade capacity target
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER
Big Business Through Cultural Cooperation Between Turkey and The US: “Move Turkey To Forward in Health
Move Turkey Forward in Healthcare with 100-billion-dollar trade capacity target
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER
PDC Therapeutics building better docetaxel therapy with nanocarrier technology
Turkey’s Promising biotech startup raises $12M in Series A Investment Round
Big Business Through Cultural Cooperation Between Turkey and The US: “Move Turkey To Forward in Health
RS Research is a biotechnology start-up discovering and developing smart nanomedicines for targeted chemotherapy. Our innovative drug delivery technology can increase the effect of chemotherapy while reducing side effects in multiple indications for a “Cure with A Smile”.